Gut Matrix - Micro PEA, BPC-157 Arginate, KPV, N-Acetyl Larazotide 201mg Blend (60 Capsules)

In stock
Lot: OR-CGMTX201-526-B1
Grade: Laboratory
60 Enteric Coated Capsules
Tested For: Heavy Metals, Microbials, Residual Solvents
U.S. Formulated: cGMP / ISO Aligned
UPS Shipping: Insurance Included
Regular price $229.99 USD
In stock
Ships Within 1 Business Day

Research Use Only

This product is limited to in vitro testing and laboratory experimentation only and is not for human or animal use or consumption of any kind. Handling and use are restricted to qualified and licensed professionals only. This product is not FDA-approved.

Compound: Micronized PEA 200mg (Palmitoylethanolamide)

Molecular Formula: C₁₈H₃₇NO₂

Molecular Weight: 299.49 g/mol

PubChem CID: 4671

CAS Number: 544-31-0

----------

Compound: BPC-157 Arginate 250mcg

Sequence:  Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Molecular Formula: C₆₂H₉₈N₁₆O₂₂·C₆H₁₄N₄O₂

Molecular Weight: 1593.76 g/mol

PubChem CID: 9941957

CAS Number: 137525-51-0

----------

Compound: KPV 250mcg

Sequence: Lys-Pro-Val

Molecular Formula: C₁₆H₃₀N₄O₄

Molecular Weight: 342.43 g/mol

PubChem CID: 125672

CAS Number: 67727-97-3

----------

Compound: N-Acetyl Larazotide 250mcg

Sequence: Ac-Gly-Gly-Val-Leu-Val-Gln-Pro-Gly-OH

Molecular Formula: C₃₂H₅₅N₉O₁₀

Molecular Weight: 725.84 g/mol

PubChem CID: 9810532

CAS Number: 258818-34-7

----------

Amount: 60 Enteric Coated Capsules. 201mg Per Two Capsules. 

  • Store capsules in their original container in a cool, dry place away from direct sunlight, heat, and moisture.
  • For long-term stability, refrigeration (2–8°C / 35–46°F) is recommended.
  • Keep capsules tightly sealed in their original container to prevent exposure to humidity.
  • Do not freeze, as extreme temperatures may affect capsule integrity or coating performance.
  • Discard any research product that appears damaged, discolored, or compromised.

Research-grade capsules manufactured in the USA, enteric-coated, and vegan. Each batch is tested for identity, net content, and bacterial contaminants, to ensure high-quality, transparent, and reliable research results.

Precision-filled for consistency and formulated with research-grade excipients to support in-vitro and analytical testing applications.

This product is limited to in vitro testing and laboratory experimentation and is not intended for human or animal use or consumption under any circumstances.

This product is not FDA approved and is not classified as a drug, food, or cosmetic. It may not be represented, marketed, or used as such.

All orders placed through OROS Research are shipped via UPS (free 2-day shipping on orders over $150), and includes full insurance in the event your package is lost, stolen, or damaged in transit.

Once your order is handed off to UPS, delivery times are no longer within our control. While most shipments arrive within 2–3 business days, delays may occur due to weather conditions, holidays, high-volume periods, or weekend inactivity, during which packages are not in transit.

To help ensure product integrity during transit, all research materials are packaged in protective boxes that shield vials from direct sunlight and temperature fluctuations. Additionally, our lyophilized (freeze-dried) research peptides are highly stable and can withstand elevated temperatures for extended periods without compromising quality or efficacy.

Rated Excellent on Trustpilot
Read our reviews

Comprehensive Capsule Quality Verification

Every OROS capsule batch is verified across five critical quality attributes—including identity, net content, heavy metals, microbial contamination, and residual solvent testing—ensuring a high level of analytical integrity, consistency, and transparency. This multi-point framework represents one of the most comprehensive testing standards in the research space.

April 2026 Update: All new capsule batches are now validated through an ISO 17025-accredited laboratory, supporting method accuracy, reproducibility, and compliance with recognized analytical standards. Microbial testing helps verify that finished capsules meet clean material expectations, while residual solvent testing helps confirm that trace processing solvents are screened and controlled before release.

Identity (LC-MS)

Verified

Utilizes LC-MS analysis to confirm the molecular identity of the compound. Identity verification is a foundational quality control measure designed to help ensure the material being tested matches the expected molecular profile.

Net Content

Passed

Verifies that the finished capsule batch meets its labeled quantity within acceptable variance, supporting consistency across each production lot.

Heavy Metals

Passed

Screens for elemental impurities such as lead, arsenic, cadmium, and mercury to support material quality and contaminant control.

Microbial Contamination

Passed

Checks for unwanted microbial presence to help confirm that finished capsules meet clean material expectations and are handled within controlled quality standards.

Residual Solvents

Passed

Evaluates trace solvent residues that may remain from manufacturing or processing, helping confirm these compounds are screened and controlled before release.

5-Amino-1MQ 50mg
0 Records
Compound: 5-Amino-1MQ 50mg
Current Lot
Net Weight
50.88mg
Lot Number
OR-LP5A150-526-B1
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
AOD-9064
0 Records
Compound: AOD-9604 5mg
Net Weight
7.48mg
Lot Number
1135493 - Batch 1
MFG Date
December 2025
EXP Date
December 2027
COA Date
January 9th 2026
Purchase Start
January 11th 2026
Purchase End
March 24th 2026
Compound: AOD-9604 5mg
Net Weight
5.21mg
Lot Number
OR-LPAOD5-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 9th 2026
Purchase End
May 14th 2026
Compound: AOD-9604 5mg
Current Lot
Net Weight
5.06mg
Lot Number
OR-LPAOD5-326-B3
MFG Date
May 2026
EXP Date
May 2028
COA Date
June 3rd 2026
Purchase Start
June 6th 2026
Purchase End
Present
ARA-290
0 Records
Compound: ARA-290 32mg
Current Lot
Net Weight
32.89mg
Lot Number
OR-LPARA32-526-B1
MFG Date
May 2026
EXP Date
May 2028
COA Date
June 3rd 2026
Purchase Start
June 6th 2026
Purchase End
Present
AURA
0 Records
Net Weight
100mg
Lot Number
938536 - Batch 1
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 18th 2025
Purchase Start
November 18th 2025
Purchase End
Present
BPC-157
0 Records
Compound: BPC-157 5mg
Net Weight
5.07mg
Lot Number
395247 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
September 23rd 2025
Compound: BPC-157 5mg
Net Weight
6.13mg
Lot Number
413358 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
September 23rd 2025
Purchase Start
September 23rd 2025
Purchase End
November 7th 2025
Compound: BPC-157 5mg
Net Weight
6.84mg
Lot Number
835571 - Batch 3
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 28th 2025
Purchase Start
November 28th 2025
Purchase End
January 19th 2026
Compound: BPC-157 10mg
Net Weight
14.52mg
Lot Number
863923 - Batch 1
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 13th 2025
Purchase Start
December 13th 2025
Purchase End
January 28th 2026
Compound: BPC-157 5mg
Net Weight
5.59mg
Lot Number
1323471 - Batch 4
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 3rd 2026
Purchase Start
February 4th 2026
Purchase End
May 16th 2026
Compound: BPC-157 10mg
Net Weight
11.16mg
Lot Number
1349811 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 3rd 2026
Purchase Start
February 4th 2026
Purchase End
March 25th 2026
Compound: BPC-157 10mg
Current Lot
Net Weight
10.06mg
Lot Number
OR-LPBPC10-626-B6
MFG Date
June 2026
EXP Date
June 2028
COA Date
June 12th 2026
Purchase Start
June 16th 2026
Purchase End
Present
Compound: BPC-157 5mg
Current Lot
Net Weight
5.02mg
Lot Number
OR-LPBPC5-526-B5
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Compound: BPC-157 10mg
Net Weight
10.16mg
Lot Number
OR-LPBPC10-326-B5
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
May 28th 2026
BPC-157 Capsules
0 Records
Net Weight
500mcg
Lot Number
73956 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 27th 2025
Purchase Start
November 6th 2025
Purchase End
April 16th 2026
Net Weight
536.59
Lot Number
OR-CBPC500-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Cartalax
0 Records
Compound: Cartalax 20mg
Current Lot
Net Weight
19.30mg
Lot Number
OR-CTX20-326 - Batch 1
MFG Date
March 2026
EXP Date
March 2028
COA Date
March 27th 2026
Purchase Start
March 27th 2026
Purchase End
Present
CJC-1295 (DAC)
0 Records
Compound: CJC-1295 DAC 5mg
Net Weight
6.04mg
Lot Number
538577 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 12th 2025
Purchase Start
October 12th 2025
Purchase End
November 30th 2025
Compound: CJC-1295 DAC 5mg
Net Weight
7.43mg
Lot Number
829471 - Batch 2
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
January 3rd 2026
Compound: CJC-1295 DAC 5mg
Net Weight
6.95mg
Lot Number
1246331 - Batch 3
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 2nd 2026
Purchase End
April 8th 2026
Compound: CJC-1295 DAC 5mg
Current Lot
Net Weight
5.16mg
Lot Number
OR-LPCJC5-426-B5
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
CJC-1295 / Ipamorelin
0 Records
Net Weight
10.30mg
Lot Number
395292 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
August 12th 2025
Purchase Start
August 12th 2025
Purchase End
September 1st 2025
Net Weight
12.06mg
Lot Number
416313 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 2nd 2025
Purchase Start
October 2nd 2025
Purchase End
October 10th 2025
Net Weight
11.8mg
Lot Number
727449 - Batch 3
MFG Date
October 2025
EXP Date
October 2027
COA Date
November 7th 2026
Purchase Start
November 10th 2025
Purchase End
November 30th 2025
Net Weight
11.35mg
Lot Number
853822 - Batch 4
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
December 26th 2025
Net Weight
9.85mg
Lot Number
1136576 - Batch 5
MFG Date
December 2025
EXP Date
December 2027
COA Date
January 9th 2026
Purchase Start
January 11th 2026
Purchase End
January 31st 2026
Net Weight
10.76mg
Lot Number
1247385 - Batch 6
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 2nd 2026
Purchase End
February 13th 2026
Net Weight
10.42mg
Lot Number
1536499 - Batch 7
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 17th 2026
Purchase Start
February 19th 2026
Purchase End
March 28th
Net Weight
22.34mg
Lot Number
1624882 - Batch 1
MFG Date
February 2026
EXP Date
February 2026
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
March 30th 2026
Net Weight
10.19mg
Lot Number
OR-LPCJCIPA10-326-B8
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
May 14th 2026
Net Weight
20.47mg
Lot Number
OR-LPCJCIPA20-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
May 19th 2026
Net Weight
10.20mg
Lot Number
OR-LPCJCIPA10-526-B9
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
June 8th 2026
Net Weight
10.20mg
Lot Number
OR-LPCJCIPA10-526-B10
MFG Date
May 2026
EXP Date
May 2028
COA Date
June 3rd 2026
Purchase Start
June 8th 2026
Purchase End
Present
Net Weight
20.28mg
Lot Number
OR-LPCJCIPA20-626-B3
MFG Date
June 2026
EXP Date
June 2028
COA Date
June 12th 2026
Purchase Start
June 16th 2026
Purchase End
Present
CJC-1295 (No DAC)
0 Records
Net Weight
5.21mg
Lot Number
395253 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
October 1st 2025
Net Weight
5.79mg
Lot Number
416355 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 2nd 2025
Purchase Start
October 2nd 2025
Purchase End
December 9th 2025
Net Weight
6.12mg
Lot Number
831643 - Batch 3
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
February 17th 2026
Net Weight
5.63mg
Lot Number
1525387 - Batch 4
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 17th 2026
Purchase Start
February 19th 2026
Purchase End
May 18th 2026
Current Lot
Net Weight
5.19mg
Lot Number
OR-LP-CJCND5-526-B5
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
DSIP
0 Records
Compound: DSIP 5mg
Net Weight
5.19mg
Lot Number
1627401 - Batch 1
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
May 12th 2026
Compound: DSIP 5mg
Current Lot
Net Weight
5.13mg
Lot Number
OR-LPDSP5-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Epithalon
0 Records
Net Weight
8.17mg
Lot Number
549788 - Batch 1
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 12th 2025
Purchase Start
October 13th 2025
Purchase End
December 21st 2025
Net Weight
18.41mg
Lot Number
1485469 - Batch 1
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 11th 2026
Purchase Start
February 12th 2026
Purchase End
March 25th 2026
Net Weight
10.14mg
Lot Number
OR-LPEPI10-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 9th 2026
Purchase End
May 14th 2026
Current Lot
Net Weight
10.04mg
Lot Number
OR-LPEPI10-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
GHK-Cu
0 Records
Compound: GHK Cu 50mg
Net Weight
49.50mg
Lot Number
395291 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 12th 2025
Purchase Start
July 15th 2025
Purchase End
October 19th 2025
Compound: GHK Cu 50mg
Net Weight
48.18mg
Lot Number
416312 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
September 23rd 2025
Purchase Start
October 20th 2025
Purchase End
December 26th 2025
Compound: GHK Cu 50mg
Net Weight
51.70mg
Lot Number
863901 - Batch 3
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 26th 2025
Purchase End
February 4th 2026
Compound: GHK Cu 50mg
Net Weight
51.04mg
Lot Number
1462133 - Batch 4
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 9th 2026
Purchase End
February 28th 2026
Compound: GHK Cu 50mg
Net Weight
55.07mg
Lot Number
1623175 - Batch 5
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
April 17th 2026
Compound: GHK Cu 50mg
Current Lot
Net Weight
51.79mg
Lot Number
OR-LPGHK50-426-B6
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
GLOW
0 Records
Net Weight
96.13mg
Lot Number
416314 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 4th 2025
Purchase Start
October 5th 2025
Purchase End
November 27th 2025
Net Weight
91.07mg
Lot Number
395293 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 12th 2025
Purchase Start
July 21st 2025
Purchase End
August 25 2025
Net Weight
68.8mg
Lot Number
1321546 - Batch 1
MFG Date
January 2026
EXP Date
January 2028
COA Date
January 12th 2026
Purchase Start
January 13th 2026
Purchase End
March 20th 2026
Net Weight
81.19mg
Lot Number
OR-GLW-326-B4
MFG Date
March 2026
EXP Date
March 2028
COA Date
March 21st 2026
Purchase Start
March 22nd 2026
Purchase End
April 27th 2026
Net Weight
72.23mg
Lot Number
OR-LPGL70-426-B5
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
GLP-1R (Reta)
0 Records
Compound: GLP-1R (GLP3) 5mg
Net Weight
5.96mg
Lot Number
427458 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 2nd 2025
Purchase Start
October 4th 2025
Purchase End
February 8th 2026
Compound: GLP-1R (GLP3) 10mg
Net Weight
11.07mg
Lot Number
395237 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 7th 2025
Purchase Start
July 15th 2025
Purchase End
October 8th 2025
Compound: GLP-1R (GLP3) 10mg
Net Weight
13.17mg
Lot Number
416347 - Batch 2
MFG Date
September 2025
EXP Date
September 2026
COA Date
September 23rd 2025
Purchase Start
October 10th 2025
Purchase End
December 8th 2025
Compound: GLP-1R (GLP3) 10mg
Net Weight
12.53mg
Lot Number
817359 - Batch 3
MFG Date
November 2025
EXP Date
November 2026
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
January 27th 2026
Compound: GLP-1R (GLP3) 20mg
Net Weight
20.07mg
Lot Number
933107 - Batch 1
MFG Date
December 2025
EXP Date
December 2026
COA Date
December 19th 2025
Purchase Start
December 19th 2025
Purchase End
April 23rd 2026
Compound: GLP-1R (GLP3) 10mg
Net Weight
10mg
Lot Number
1316243 - Batch 4
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 3rd 2026
Purchase Start
February 4th 2026
Purchase End
March 9th 2026
Compound: GLP-1R (GLP3) 5mg
Net Weight
5.54mg
Lot Number
1473244 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 9th 2026
Purchase End
May 5th 2026
Compound: GLP-1R (GLP3) 10mg
Net Weight
10.88mg
Lot Number
1724211 - Batch 5
MFG Date
February 2026
EXP Date
February 2028
COA Date
March 10th 2026
Purchase Start
March 11th 2026
Purchase End
May 5th 2026
Compound: GLP-1R (GLP3) 20mg
Net Weight
20.86mg
Lot Number
OR-LPGLPR10-326-B2
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 9th 2026
Purchase Start
April 23rd 2026
Purchase End
June 1st 2026
Compound: GLP-1R (GLP3) 10mg
Current Lot
Net Weight
10.26mg
Lot Number
OR-LPGLPR10-426-B6
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
Compound: GLP-1R (GLP3) 5mg
Current Lot
Net Weight
5.19mg
Lot Number
OR-LPGLPR5-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
GLP-1S (Sema)
0 Records
Compound: GLP-1S (GLP1) 5mg
Current Lot
Net Weight
5.45mg
Lot Number
395255 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
Present
Compound: GLP-1S (GLP1) 10mg
Net Weight
10.66mg
Lot Number
395224 - Batch 1
MFG Date
July 2025
EXP Date
July 2026
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
November 1st 2025
Compound: GLP-1S (GLP1) 10mg
Net Weight
13.99mg
Lot Number
877136 - Batch 2
MFG Date
November 2025
EXP Date
November 2026
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
April 9th 2026
Compound: GLP-1S (GLP1) 10mg
Current Lot
Net Weight
10.33mg
Lot Number
OR-LPGLPS10-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
GLP-1T (Tirz)
0 Records
Compound: GLP-1T (GLP2) 5mg
Net Weight
5.30mg
Lot Number
395255 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
May 5th 2026
Compound: GLP-1T (GLP2) 10mg
Net Weight
10.18mg
Lot Number
876254 - Batch 2
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 12th 2025
Purchase Start
January 13th 2025
Purchase End
April 7th 2026
Compound: GLP-1T (GLP2) 10mg
Net Weight
10.64mg
Lot Number
395236 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
January 12th 2025
Compound: GLP-1T (GLP2) 10mg
Current Lot
Net Weight
10.23mg
Lot Number
OR-LPGLPT10-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
Compound: GLP-1T (GLP2) 5mg
Current Lot
Net Weight
5.31mg
Lot Number
OR-LPGLPT5-426-B2
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
May 5th 2026
Purchase End
Present
Gut Matrix
0 Records
Net Weight
207.13mg
Lot Number
OR-CGMTX201-526-B1
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Ipamorelin
0 Records
Compound: Ipamorelin 5mg
Net Weight
5.47mg
Lot Number
395256 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
October 20th 2025
Compound: Ipamorelin 5mg
Net Weight
6.09mg
Lot Number
416367 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
September 23rd 2025
Purchase Start
October 20th 2025
Purchase End
January 31st 2026
Compound: Ipamorelin 5mg
Net Weight
5.01mg
Lot Number
1243137 - Batch 3
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 2nd 2026
Purchase End
April 8th 2026
Compound: Ipamorelin 5mg
Current Lot
Net Weight
5.24mg
Lot Number
OR-LPIPA5-426-B4
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
Present
Kisspeptin-10
0 Records
Compound: Kisspeptin-10 5mg
Current Lot
Net Weight
5.16mg
Lot Number
OR-LPKISS5-626-B2
MFG Date
June 2026
EXP Date
June 2028
COA Date
June 12th 2026
Purchase Start
June 16th 2026
Purchase End
Present
Compound: Kisspeptin-10 5mg
Net Weight
4.78mg
Lot Number
359289 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 12th 2025
Purchase Start
July 15th 2025
Purchase End
May 15th 2026
KLOW
0 Records
Net Weight
83.31mg
Lot Number
943117 - Batch 1
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 17th 2025
Purchase Start
December 17th 2025
Purchase End
March 26th 2026
Net Weight
88.47mg
Lot Number
OR-LPKLO80-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 1st 2026
Purchase Start
April 1st 2026
Purchase End
April 10th 2026
Net Weight
83.34mg
Lot Number
OR-LPKLO80-326-B3
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
May 10th 2026
Net Weight
82.46mg
Lot Number
OR-LPKLO80-526-B4
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
KPV
0 Records
Compound: KPV 15mg
Net Weight
15.96mg
Lot Number
793221 - Batch 1
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 15th 2025
Purchase Start
November 15th 2025
Purchase End
April 28th 2026
Compound: KPV 15mg
Current Lot
Net Weight
15.39mg
Lot Number
OR-LPKPV15-426-B2
MFG Date
April 2026
EXP Date
April 2026
COA Date
April 16th 2026
Purchase Start
April 29th 2026
Purchase End
Present
Melanotan-2
0 Records
Compound: Melanotan-2 10mg
Net Weight
10.74mg
Lot Number
395221 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
September 15th 2025
Compound: Melanotan-2 10mg
Net Weight
9.77mg
Lot Number
395362 - Batch 2
MFG Date
August 2025
EXP Date
August 2027
COA Date
August 23rd 2025
Purchase Start
September 16th 2025
Purchase End
November 27th 2025
Compound: Melanotan-2 10mg
Net Weight
12.18mg
Lot Number
8714419 - Batch 3
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 12th 2025
Purchase Start
December 12th 2025
Purchase End
February 28th 2026
Compound: Melanotan-2 10mg
Net Weight
9.88mg
Lot Number
1621439 - Batch 4
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2028
Purchase Start
February 28th 2028
Purchase End
March 30th 2026
Compound: Melanotan-2 10mg
Current Lot
Net Weight
10.14mg
Lot Number
OR-LPMT2-626-B6
MFG Date
June 2026
EXP Date
June 2028
COA Date
June 12th 2026
Purchase Start
June 16th 2026
Purchase End
Present
Compound: Melanotan-2 10mg
Net Weight
10.18mg
Lot Number
OR-LPMT2-426-B5
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
May 18th 2026
MOTS-C
0 Records
Compound: MOTS-C 10mg
Net Weight
9.77mg
Lot Number
395233 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
September 30th 2025
Compound: MOTS-C 10mg
Net Weight
11.68mg
Lot Number
855216 - Batch 3
MFG Date
November 2025
EXP Date
November 2026
COA Date
December 8th 2025
Purchase Start
December 9th 2025
Purchase End
January 10th 2026
Compound: MOTS-C 10mg
Net Weight
9.63mg
Lot Number
416344 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 6th 2025
Purchase Start
October 6th 2025
Purchase End
November 21st 2025
Compound: MOTS-C 10mg
Net Weight
10.84mg
Lot Number
1125231 - Batch 4
MFG Date
December 2025
EXP Date
December 2025
COA Date
January 9th 2026
Purchase Start
January 11th 2026
Purchase End
February 6th 2026
Compound: MOTS-C 10mg
Net Weight
10.13mg
Lot Number
1244163 - Batch 5
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 7th 2026
Purchase End
February 26th 2026
Compound: MOTS-C 10mg
Net Weight
9.82mg
Lot Number
1622733 - Batch 6
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
April 4th 2026
Compound: MOTS-C 10mg
Current Lot
Net Weight
10.31mg
Lot Number
OR-LPMOTS10-626-B8
MFG Date
June 2026
EXP Date
June 2028
COA Date
June 12th 2026
Purchase Start
June 16th 2026
Purchase End
Present
Compound: MOTS-C 20mg
Current Lot
Net Weight
20.78mg
Lot Number
OR-LPMOTS20-426-B1
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 13th 2026
Purchase Start
May 14th 2026
Purchase End
Present
Compound: MOTS-C 10mg
Net Weight
10.29mg
Lot Number
OR-LPMOTS10-426-B7
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
June 2nd 2026
NAD+
0 Records
Compound: NAD+ 500mg
Net Weight
549.12mg
Lot Number
398321 - Batch 1
MFG Date
August 2025
EXP Date
August 2027
COA Date
September 6th 2025
Purchase Start
September 15th 2025
Purchase End
November 19th 2025
Compound: NAD+ 500mg
Net Weight
544.17mg
Lot Number
996575 - Batch 2
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 30th 2025
Purchase Start
December 30th 2025
Purchase End
February 2nd 2026
Compound: NAD+ 500mg
Net Weight
499.44mg
Lot Number
1781124 - Batch 3
MFG Date
February 2026
EXP Date
February 2028
COA Date
March 10th 2026
Purchase Start
March 11th 2026
Purchase End
April 30th 2026
Compound: NAD+ 500mg
Current Lot
Net Weight
519.47mg
Lot Number
OR-LPNAD500-426-B4
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 23rd 2026
Purchase Start
April 30th 2026
Purchase End
Present
Pinealon
0 Records
Compound: Pinealon 20mg
Current Lot
Net Weight
21.57mg
Lot Number
1746845 - Batch 1
MFG Date
February 2026
EXP Date
February 2028
COA Date
March 10th 2026
Purchase Start
March 11th 2026
Purchase End
Present
PT-141
0 Records
Compound: PT-141 10mg
Net Weight
11.59mg
Lot Number
998557 - Batch 1
MFG Date
December 2025
EXP Date
December 2027
COA Date
January 5th 2026
Purchase Start
January 6th 2026
Purchase End
March 1st 2026
Compound: PT-141 10mg
Net Weight
10.30mg
Lot Number
1434582 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
March 1st 2026
Purchase End
April 30th 2026
Compound: PT-141 10mg
Current Lot
Net Weight
10.08mg
Lot Number
OR-LPPT10-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
Reconstitution Solution
0 Records
REGEN
0 Records
Net Weight
40.56mg
Lot Number
1513276 - Batch 1
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 17th 2026
Purchase Start
February 19th 2026
Purchase End
June 6th 2026
Net Weight
40.46mg
Lot Number
OR-LPREGEN40-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
June 3rd 2026
Purchase Start
June 6th 2026
Purchase End
Present
Selank N-Acetyl Amidate
0 Records
Net Weight
9.51mg
Lot Number
1626694 - Batch 1
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
May 21st 2026
Current Lot
Net Weight
10.19mg
Lot Number
OR-LPNASLK10-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Semax N-Acetyl Amidate
0 Records
Net Weight
29.12mg
Lot Number
1625200 - Batch 1
MFG Date
February 2026
EXP Date
February 2026
COA Date
February 28th 2026
Purchase Start
February 28th 2026
Purchase End
April 29th 2026
Current Lot
Net Weight
31.27mg
Lot Number
OR-LPNASMX30-526-B2
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
Semax / Selank N-Acetyl
0 Records
Net Weight
15.97mg
Lot Number
983653 - Batch 1
MFG Date
December 2025
EXP Date
December 2027
COA Date
December 26th 2025
Purchase Start
December 26th 2025
Purchase End
April 6th 2026
Net Weight
15.25mg
Lot Number
OR-LPNASML15-326-B2
MFG Date
March 2026
EXP Date
March 2028
COA Date
March 31st
Purchase Start
April 6th 2026
Purchase End
Present
Sermorelin
0 Records
Compound: Sermorelin 5mg
Net Weight
4.23mg
Lot Number
395297 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 12th 2025
Purchase Start
July 15th 2025
Purchase End
October 10th 2025
Compound: Sermorelin 5mg
Net Weight
5.04mg
Lot Number
416318 - Batch 2
MFG Date
September 2025
EXP Date
September 2027
COA Date
September 23rd 2025
Purchase Start
October 10th 2025
Purchase End
February 1st 2026
Compound: Sermorelin 5mg
Net Weight
5.90mg
Lot Number
1451922 - Batch 3
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 9th 2026
Purchase End
April 29th 2026
Compound: Sermorelin 5mg
Current Lot
Net Weight
5.20mg
Lot Number
OR-LPSERM5-426-B4
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 29th 2026
Purchase End
Present
Sermorelin / Ipamorelin
0 Records
Net Weight
14.24mg
Lot Number
795263 - Batch 1
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 15th 2025
Purchase Start
November 15th 2025
Purchase End
January 22nd 2026
Net Weight
9.67mg
Lot Number
1245860 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 1st 2026
Purchase Start
February 2nd 2026
Purchase End
April 21st 2026
Net Weight
10.21mg
Lot Number
OR-LPSERMIPA10-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
SLU-PP-332 Capsules
0 Records
Current Lot
Net Weight
1053.16mcg/Capsule
Lot Number
OR-CSLU1000-426-B1
MFG Date
April 2026
EXP Date
April 2027
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
SS-31, MOTS-C Blend
0 Records
Net Weight
20.40mg
Lot Number
OR-LPSSMC20-326-B1
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
April 26th 2026
Current Lot
Net Weight
20.11mg
Lot Number
OR-LPSSMC20-526-B2
MFG Date
May 2026
EXP Date
May2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
Present
TB-500
0 Records
Net Weight
5.54mg
Lot Number
395234 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 23rd 2025
Purchase End
November 21st 2025
Current Lot
Net Weight
5.18mg
Lot Number
OR-LPTB5-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
June 15th 2026
Purchase End
Present
Net Weight
9.94mg
Lot Number
427456 - Batch 1
MFG Date
September 2025
EXP Date
September 2027
COA Date
October 4th 2025
Purchase Start
October 6th 2025
Purchase End
January 13th 2026
Net Weight
9.94mg
Lot Number
1356233 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
January 12th 2026
Purchase Start
January 13th 2026
Purchase End
April 9th 2026
Current Lot
Net Weight
10.22mg
Lot Number
OR-LPTB10-326-B5
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th
Purchase End
Present
Net Weight
6.24mg
Lot Number
825570 - Batch 2
MFG Date
November 2025
EXP Date
November 2027
COA Date
November 28th 2025
Purchase Start
November 28th 2025
Purchase End
June 14th 2026
Tesamorelin
0 Records
Compound: Tesamorelin 5mg
Net Weight
5.76mg
Lot Number
395254 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 3rd 2025
Purchase Start
July 15th 2025
Purchase End
September 2nd 2025
Compound: Tesamorelin 5mg
Net Weight
6.63mg
Lot Number
398321 - Batch 2
MFG Date
August 2025
EXP Date
August 2027
COA Date
September 15th 2025
Purchase Start
September 15th 2025
Purchase End
October 23rd 2025
Compound: Tesamorelin 5mg
Net Weight
5.34mg
Lot Number
74659 - Batch 3
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 31st 2025
Purchase Start
October 31st 2025
Purchase End
January 29th 2026
Compound: Tesamorelin 5mg
Net Weight
5.20mg
Lot Number
1449647 - Batch 4
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 9th 2026
Purchase End
March 13th 2026
Compound: Tesamorelin 5mg
Net Weight
5.11mg
Lot Number
OR-LPTES5-326-B5
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
May 13th 2026
Compound: Tesamorelin 10mg
Current Lot
Net Weight
10.14mg
Lot Number
OR-LPTES10-426-B1
MFG Date
May 2026
EXP Date
May 20228
COA Date
May 2nd 2026
Purchase Start
May 14th 2026
Purchase End
Present
Compound: Tesamorelin 5mg
Current Lot
Net Weight
5.11mg
Lot Number
OR-LPTES5-626-B7
MFG Date
June 2026
EXP Date
June 2028
COA Date
June 12th 2026
Purchase Start
June 16th 2026
Purchase End
Present
Compound: Tesamorelin 5mg
Net Weight
5.06mg
Lot Number
OR-LPTES5-526-B6
MFG Date
May 2026
EXP Date
May 2028
COA Date
May 18th 2026
Purchase Start
May 21st 2026
Purchase End
June 15th 2026
Tesamorelin / Ipamorelin
0 Records
Net Weight
20.34mg
Lot Number
776843 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
November 7th 2025
Purchase Start
November 7th 2025
Purchase End
February 20th 2026
Net Weight
21.02mg
Lot Number
1427354 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 9th 2026
Purchase Start
February 20th 2026
Purchase End
March 30th 2026
Net Weight
20.39mg
Lot Number
OR-LPTESIPA20-426-B3
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
June 9th 2026
Net Weight
20.33mg
Lot Number
OR-LPTESIPA20-626-B4
MFG Date
June 2026
EXP Date
June 2028
COA Date
June 12th 2026
Purchase Start
June 16th 2026
Purchase End
Present
Testagen
0 Records
Compound: Testagen 20mg
Current Lot
Net Weight
20.58mg
Lot Number
OR-LPTST20-426-B1
MFG Date
April 2026
EXP Date
April 2028
COA Date
May 2nd 2026
Purchase Start
May 5th 2026
Purchase End
Present
Thymosin Alpha-1
0 Records
Current Lot
Net Weight
5.18mg
Lot Number
OR-LPTA5-326-B1
MFG Date
March 2026
EXP Date
March 2028
COA Date
April 9th 2026
Purchase Start
April 10th 2026
Purchase End
Present
Wolverine - BPC-157 / TB-500
0 Records
Net Weight
11.25mg
Lot Number
395253 - Batch 1
MFG Date
June 2025
EXP Date
June 2027
COA Date
July 4th 2025
Purchase Start
July 15th 2025
Purchase End
September 29th 2025
Net Weight
11.17mg
Lot Number
817358 - Batch 2
MFG Date
November 2025
EXP Date
November 2027
COA Date
December 8th 2025
Purchase Start
December 8th 2025
Purchase End
December 31st 2025
Net Weight
21.94mg
Lot Number
1248671 - Batch 2
MFG Date
January 2026
EXP Date
January 2028
COA Date
January 13th 2026
Purchase Start
January 13th 2026
Purchase End
February 8th 2026
Net Weight
20.19mg
Lot Number
527457 - Batch 1
MFG Date
October 2025
EXP Date
October 2027
COA Date
October 12th 2025
Purchase Start
October 13th 2025
Purchase End
November 18th 2025
Net Weight
12.15mg
Lot Number
1338536 - Batch 3
MFG Date
January 2026
EXP Date
January 2028
COA Date
February 3rd 2026
Purchase Start
February 4th 2026
Purchase End
April 6th 2026
Net Weight
21.98mg
Lot Number
1547512 - Batch 3
MFG Date
February 2026
EXP Date
February 2028
COA Date
February 17th 2026
Purchase Start
February 19th 2026
Purchase End
April 23rd 2026
Net Weight
10.49mg
Lot Number
OR-LPBPCTB10-426-B4
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 16th 2026
Purchase Start
April 17th 2026
Purchase End
June 9th 2026
Net Weight
20.32mg
Lot Number
OR-LPBPCTB20-326-B4
MFG Date
April 2026
EXP Date
April 2028
COA Date
April 9th 2026
Purchase Start
April 23rd 2026
Purchase End
May 28th 2026
Net Weight
20.28mg
Lot Number
OR-LPBPCTB20-626-B5
MFG Date
June 2026
EXP Date
June 2028
COA Date
June 12th 2026
Purchase Start
June 16th 2026
Purchase End
Present
Net Weight
10.12mg
Lot Number
OR-LPBPCTB10-526-B5
MFG Date
May 2026
EXP Date
May 2028
COA Date
June 3rd 2026
Purchase Start
June 9th 2026
Purchase End
Present

Science Without Shortcuts™

Founded in 2025, OROS Research was created with a singular mission: to bring integrity, transparency, and uncompromising quality to the research peptide industry. Born out of frustration with a market saturated by corner-cutting and profit-first mindsets, we set out to redefine what researchers should expect and deserve.

At OROS, we formulate and finish our peptides in California in an ISO 5 Laminar Flow Facility following cGMP standards, ensuring every product meets the highest standards of purity, and precision. We don’t just claim quality, we prove it through rigorous testing and verifiable third-party COAs provided by licensed testing facilities in the U.S.

Built by researchers, for researchers, we believe in doing things the right way. No shortcuts, no gray areas, and no false promises. Just high-purity, genuine USA-formulated peptides, reliable service, and a relentless focus on helping our research customers achieve meaningful results.

Learn More

Capsule Quality & Testing FAQ

Answers to our most common questions.

What are OROS capsule products intended for?

OROS capsule products are intended strictly for research use only. They are not intended for human or animal consumption, medical use, diagnostic use, or cosmetic applications.


Compared to loose powders and bulk materials, capsule formulations provide researchers with a more convenient and standardized format that can help support consistency in handling, storage, transport, inventory management, and unit-to-unit quantity control.

How are OROS capsule products tested?

Every OROS capsule batch undergoes independent third-party testing in the United States. Our current capsule testing program includes identity verification, net content validation, heavy metals screening, microbial contamination testing, and residual solvent analysis.


We believe these five testing categories provide a comprehensive view of finished product quality by helping verify ingredient identity, labeled content, manufacturing consistency, and contaminant control.

Who performs your testing?

As of April 2026, all new capsule batches are validated through an ISO/IEC 17025-accredited laboratory. ISO 17025 accreditation is an internationally recognized quality standard that supports analytical accuracy, method validation, reproducibility, and traceability.


We believe utilizing accredited third-party laboratories provides an additional level of confidence and transparency in our quality control program.

Why don't you publish purity percentages for capsule products?

One thing we intentionally avoid is advertising “purity percentages” for finished capsule products because, scientifically speaking, purity analysis on blended capsule formulations is often misleading and not analytically representative in the same way it is for isolated raw materials.


Capsule formulations frequently contain multiple active ingredients, excipients, flow agents, and other formulation components. As a result, a traditional purity percentage does not necessarily provide meaningful information about the overall quality of the finished product.


Instead, we focus on testing methods that are directly relevant to finished capsule products, including identity verification, net content validation, heavy metals screening, microbial testing, and residual solvent analysis.

Why don't you test capsule products for endotoxins?

Endotoxin testing is generally most relevant for sterile products and materials used in applications where bacterial endotoxins are a primary quality concern. Finished capsule products are evaluated differently because they are not sterile lyophilized materials and are not intended for sterile applications.


For capsule products, we focus on testing categories that are more appropriate and meaningful for the finished dosage format: identity, net content, heavy metals, microbial contamination, and residual solvents. In our view, these tests provide a more relevant quality profile for capsules than endotoxin testing.

What are residual solvents and why do they matter?

Residual solvents are trace amounts of processing solvents that may be utilized during synthesis, extraction, purification, formulation, or manufacturing workflows. While a product may successfully pass other analytical tests, residual solvent analysis provides additional insight into manufacturing quality, purification efficiency, and post-processing controls.


Our current residual solvent screening panel includes: Acetonitrile, Methanol, TFA, DMF, Dichloromethane, Diethyl Ether, Isopropanol/Ethanol, and THF.


For capsule products, THF screening can be particularly valuable due to the potential for solvent exposure during certain upstream manufacturing, extraction, formulation, or encapsulation-related processes.

Why do you test for microbial contamination?

Microbial testing helps verify that finished capsule products meet established microbiological quality standards. This screening evaluates overall microbial burden as well as the presence of specified organisms that may indicate poor manufacturing, handling, packaging, or storage conditions.


We believe microbial testing is an essential component of a comprehensive quality control program because it helps confirm products are manufactured and handled under controlled conditions.

Why do you test for heavy metals?

Heavy metals such as lead, arsenic, cadmium, and mercury can occur naturally within raw materials or be introduced through manufacturing and environmental processes. Heavy metal screening helps verify that these elemental impurities remain within established specifications.


We believe heavy metal testing is a critical component of finished product quality assurance and contaminant control.

What is net content testing?

Net content testing verifies that finished capsule products contain the quantity stated on the label within acceptable manufacturing tolerances. This testing helps support batch-to-batch consistency and confirms that products are filled according to established specifications.

What is identity testing?

Identity testing helps confirm that the material being analyzed matches the expected ingredient or compound. Identity verification serves as the foundation of our testing program and helps ensure that products are accurately characterized before release.

Where can I find testing results?

Current and historical testing reports can be found within our Lab Results Library. Available documentation may include lot numbers, manufacturing dates, expiration dates, Certificates of Analysis (COAs), and supporting analytical reports depending on the product and batch.

Where are your products manufactured?

OROS products are manufactured in the USA through qualified third-party manufacturing partners operating under controlled quality systems. Raw materials may be sourced domestically or internationally depending on availability, quality standards, and supplier qualification requirements.

Why do you not source your raw materials exclusively from the USA?

Many raw materials and specialty ingredients used across the broader supplement, research, and pharmaceutical supply chains are sourced internationally. Our manufacturing partners source domestically when possible; however, it is not always feasible to source 100% of raw materials exclusively from the United States.


What matters most is supplier qualification, manufacturing controls, and finished batch testing. Every OROS capsule batch is independently tested before release to support quality, consistency, and transparency.

How are capsule products shipped?

All orders are shipped from North Carolina via UPS, with your choice of Ground, 2-Day, or Express services. Orders over $150 receive free UPS 2-Day shipping. Every order includes full shipment insurance at no additional cost.

Where do you ship?

We currently ship to U.S. addresses only. We do not ship to PO Boxes, international destinations, military bases, or U.S. territories.

What payment methods do you accept?

We accept all major debit and credit cards, including American Express. HSAs and FSAs are not accepted.


After checkout, you must complete our secure Payment Authorization Form. Orders are not processed or shipped until authorization is completed. This workflow ensures PCI compliance and protects your payment data.

Do you accept returns?

All sales are final. If an issue occurs with your order, please contact support@orosresearch.com within 7 days of delivery.

How should capsule products be stored?

Store capsule products in a cool, dry environment away from direct sunlight, heat, moisture, and humidity. Keep the container tightly sealed when not in use and follow any storage instructions listed on the product label.

Looking for more answers?

Visit our Full FAQ Page for detailed information on storage, COAs, shipping, policies, and additional support.